The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so back to my question which is if you just look at the cost of sequencing from 2000 till today it's sort of like two curves right there's like the the Relentless curve that you know we gets to where we are in 20133 but then there was another big drop in price that occurred after that and and I'm I'm guessing that had to do with shotgun sequencing or the commercialization of it
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.